Creative Planning’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.9M Buy
37,170
+1,007
+3% +$646K 0.01% 425
2025
Q4
$24.5M Buy
36,163
+2,894
+9% +$1.97M 0.02% 321
2025
Q3
$21.3M Buy
33,269
+4,201
+14% +$2.55M 0.02% 349
2025
Q2
$15.6M Buy
29,068
+3,052
+12% +$1.46M 0.01% 392
2025
Q1
$10.9M Buy
26,016
+1,798
+7% +$781K 0.01% 456
2024
Q4
$10M Sell
24,218
-218
-0.9% -$95.6K 0.01% 445
2024
Q3
$12.3M Buy
24,436
+614
+3% +$298K 0.01% 383
2024
Q2
$11.6M Sell
23,822
-303
-1% -$152K 0.01% 375
2024
Q1
$13M Buy
24,125
+616
+3% +$337K 0.01% 346
2023
Q4
$13M Buy
23,509
+1,970
+9% +$925K 0.02% 329
2023
Q3
$9.42M Buy
21,539
+5,873
+37% +$2.93M 0.01% 370
2023
Q2
$7.87M Buy
15,666
+522
+3% +$250K 0.01% 400
2023
Q1
$7.57M Buy
15,144
+259
+2% +$124K 0.01% 398
2022
Q4
$6.07M Buy
14,885
+1,781
+14% +$691K 0.01% 439
2022
Q3
$4.27M Sell
13,104
-379
-3% -$139K 0.01% 471
2022
Q2
$4.73M Sell
13,483
-59
-0.4% -$24.1K 0.01% 469
2022
Q1
$7.41M Buy
13,542
+1,528
+13% +$804K 0.01% 369
2021
Q4
$7.91M Buy
12,014
+16
+0.1% +$10K 0.01% 329
2021
Q3
$7.46M Buy
11,998
+307
+3% +$206K 0.01% 323
2021
Q2
$7.38M Sell
11,691
-218
-2% -$120K 0.01% 320
2021
Q1
$5.83M Buy
11,909
+463
+4% +$232K 0.01% 375
2020
Q4
$5.72M Sell
11,446
-405
-3% -$181K 0.01% 349
2020
Q3
$4.66M Buy
11,851
+678
+6% +$251K 0.01% 322
2020
Q2
$3.69M Sell
11,173
-1,006
-8% -$291K 0.01% 334
2020
Q1
$2.95M Sell
12,179
-210
-2% -$54.8K 0.01% 335
2019
Q4
$3.23M Sell
12,389
-537
-4% -$142K 0.01% 379
2019
Q3
$3.52M Sell
12,926
-8,805
-41% -$2.45M 0.01% 359
2019
Q2
$5.98M Sell
21,731
-51
-0.2% -$12.6K 0.02% 254
2019
Q1
$4.87M Sell
21,782
-276
-1% -$57K 0.02% 285
2018
Q4
$4.1M Buy
22,058
+475
+2% +$97.4K 0.02% 282
2018
Q3
$5.39M Buy
21,583
+212
+1% +$51.5K 0.02% 255
2018
Q2
$4.66M Sell
21,371
-38
-0.2% -$7.83K 0.02% 264
2018
Q1
$4.1M Buy
21,409
+7,857
+58% +$1.45M 0.02% 297
2017
Q4
$2.12M Sell
13,552
-7,923
-37% -$1.25M 0.01% 440
2017
Q3
$3.34M Sell
21,475
-809
-4% -$128K 0.02% 316
2017
Q2
$3.6M Buy
22,284
+2,104
+10% +$342K 0.02% 281
2017
Q1
$3.12M Buy
20,180
+4,402
+28% +$607K 0.02% 303
2016
Q4
$1.85M Buy
15,778
+5,794
+58% +$661K 0.01% 424
2016
Q3
$1.13M Buy
9,984
+329
+3% +$34.7K 0.01% 552
2016
Q2
$897K Buy
9,655
+6,115
+173% +$525K 0.01% 554
2016
Q1
$277K Sell
3,540
-230
-6% -$16.6K ﹤0.01% 1036
2015
Q4
$275K Buy
3,770
+765
+25% +$54.6K ﹤0.01% 1040
2015
Q3
$223K Buy
+3,005
New +$215K ﹤0.01% 1136
2015
Q2
Sell
-2,360
Closed -$182K 1966
2015
Q1
$182K Sell
2,360
-224
-9% -$17.4K ﹤0.01% 1241
2014
Q4
$192K Buy
2,584
+554
+27% +$38.9K ﹤0.01% 1162
2014
Q3
$120K Buy
2,030
+30
+2% +$1.9K ﹤0.01% 1353
2014
Q2
$134K Sell
2,000
-300
-13% -$19.1K ﹤0.01% 1248
2014
Q1
$140K Hold
2,300
﹤0.01% 1188
2013
Q4
$122K Buy
2,300
+180
+8% +$9.47K ﹤0.01% 1086
2013
Q3
$106K Buy
2,120
+120
+6% +$5.77K ﹤0.01% 1078
2013
Q2
$90K Buy
+2,000
New +$87.4K ﹤0.01% 1043

Other funds holding IDXX

Creative Planning's IDXX Position: Q1 2026 in Review

Creative Planning increased its Idexx Laboratories (IDXX) stake by 2.8% in Q1 2026, buying an estimated $646K and bringing the position to 37,170 shares worth $20.9M. The position accounts for 0.01% of the portfolio, ranked #425.

Creative Planning first reported a position in IDXX in Q2 2013 and has held it in 51 quarters since. The position peaked at $24.5M in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Creative Planning held 37,170 shares of Idexx Laboratories worth $20.9M as of Q1 2026.
  • Creative Planning bought 1,007 Idexx Laboratories shares in Q1 2026, an estimated $646K.
  • Idexx Laboratories made up 0.01% of Creative Planning's portfolio in Q1 2026, its #425 holding.
  • Creative Planning first reported a position in Idexx Laboratories in Q2 2013 and has held it in 51 quarters since.
  • Creative Planning's Idexx Laboratories position peaked at $24.5M in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.